Collateral damage: Paper — and editorial, and author’s response — retracted in one fell swoop

euro jA journal has retracted the results of a clinical trial comparing strategies for bladder tumors after the authors mischaracterized the way patients were assigned to each procedure.

In addition, the journal European Urology has pulled a string of correspondence between author Harry Herr at Memorial Sloan Kettering Cancer Center and an outside expert, who had questioned aspects of the study totally unrelated to the methodology, such as its generalizability.

Here’s the retraction notice for ” Randomized Trial of Narrow-band Versus White-light Cystoscopy for Restaging (Second-look) Transurethral Resection of Bladder Tumors:”  Continue reading Collateral damage: Paper — and editorial, and author’s response — retracted in one fell swoop

Journal pulls abstract author didn’t submit

A journal has retracted an abstract after discovering the author didn’t submit it — and also because it appears “highly similar” to a previous publication in Chinese.

The abstract was presented at the 2nd International Conference on Biomedicine and Pharmaceutics in 2014, and lists Qing Guo as the sole author, based Wuhan, China at the China University of Geosciences.

According to the retraction notice, published in the Journal of Investigative Medicine last December, the organizer of the conference discovered Guo hadn’t consented to publish the abstract — moreover, it appeared to overlap with another article in Chinese, written by different authors: Continue reading Journal pulls abstract author didn’t submit

Uranium study pulled after author says data were falsified

Journal of the European Ceramic SocietyA researcher has pulled a paper about uranium oxide fuel pellets after notifying the journal the data had been falsified — and, what’s more, the publisher can’t verify the identities of the co-authors. 

Originally, the Journal of the European Ceramic Society paper suggested a way to increase the compatibility of uranium oxide fuel pellets, which are usually used in nuclear reactors, at high temperatures.  

Here’s the retraction notice: Continue reading Uranium study pulled after author says data were falsified

Author of retracted math paper defends against plagiarism charge, threatens to sue journal

A researcher in Egypt is threatening to sue a mathematics journal if it doesn’t un-retract one of his papers.

The American Journal of Computational Mathematics in May retracted Mostafa M. A. Khater‘s 2015 paper, “The Modified Simple Equation Method and Its Applications in Mathematical Physics and Biology.” The retraction notice is sparse on the details, indicating only that the article was not up to snuff: Continue reading Author of retracted math paper defends against plagiarism charge, threatens to sue journal

Study of air quality around Damien Hirst’s artwork retracted — against most authors’ wishes

via Flickr Commons
Damien Hirst’s “Away From The Flock” — exhibited at Tate Britain, via Flickr Commons

The corresponding author of the study that detected toxic leaks from the work of prominent British artist Damien Hirst has now retracted it — but most of his co-authors disagree with the decision.

The April Analytical Methods study was covered extensively by the media when it suggested staff at Damien Hirst’s 2012 exhibition at Tate Gallery in London of dead animals embalmed in formaldehyde were being exposed to higher than recommended levels of the carcinogen. 

Tate and Hirst’s company, Science Limited, immediately objected to the results; we’ve obtained what appears to be letter from a lawyer for Science Limited to the corresponding author of the paper — Pier Giorgio Righetti of the Polytechnic University of Milan in Italy — saying it was “deeply concerned and troubled by the claims” in the paper.

Last month, the journal issued an expression of concern (EOC) for the paper, nothing the data may not be reliable, and on July 15, Righetti announced in a joint statement with Hirst’s company that he will be retracting his study.

Now, the paper has been officially retracted, noting more recent measurements show formaldehyde levels to be much lower than originally reported. But most of Righetti’s co-authors disagree with the decision, the notice says:  Continue reading Study of air quality around Damien Hirst’s artwork retracted — against most authors’ wishes

Does dose matter? Tumor killer paper thought so, now must retract

Molecular Medicine ReportsAfter questions from a reader, researchers took a second look at their data about the effects of a vitamin A metabolite on tumor cells, and realized their key finding was inaccurate.

They’re now retracting the paper, from Molecular Medicine Reports, because it originally reported that higher concentrations of retinoic acid (RA) were more effective in curbing the proliferation of brain tumor cells. But it seems that the RA dose made less of a difference than they originally believed, according to the retraction notice:

Continue reading Does dose matter? Tumor killer paper thought so, now must retract

Five more retractions for researcher who sued PubPeer commenters brings tally to 18

Fazlul Sarkar
Fazlul Sarkar

A cancer researcher who tried to sue PubPeer commenters for criticizing his work has earned five more retractions, bringing his total to 18. 

All of the new retractions for Fazlul Sarkar, formerly based at Wayne State University in Michigan, appear in the International Journal of Cancer. All cite an institutional investigation, and relate to issues with images.

With 18 retractions, Sarkar has now earned a spot on our leaderboard.

We first encountered Sarkar when he subpoenaed PubPeer to reveal the names of anonymous commenters that potentially cost him a job at the University of Mississippi. Earlier this month, a Wayne State spokesperson confirmed to us that Sarkar has now retired from the university. (To get up to speed, check out our timeline on the major events in this case.)

Here’s the first of the retraction notices, issued today: Continue reading Five more retractions for researcher who sued PubPeer commenters brings tally to 18

University says no misconduct in campus rape paper

swartout3
Kevin Swartout

Research integrity officials at Georgia State University say a psychology researcher did not commit misconduct in a controversial 2015 paper in JAMA Pediatrics which challenged the notion that most rapists on college campuses are repeat offenders.

GSU launched the inquiry after an outside researcher questioned the validity of data supplied to him by Kevin Swartout.

Brenda Chapman, associate VP for research integrity, told us in an e-mail that the investigation cleared Swartout of wrongdoing: Continue reading University says no misconduct in campus rape paper

Where was chem research conducted? Not here, say two of three listed author affiliations

ChemosphereA researcher has retracted two 2016 papers after discovering problems with the data that negated the findings — and after one of his three listed affiliations denied the research was conducted there.

According to the retraction notices issued by Chemosphere, Hong-Wei Luo incorrectly claimed to be affiliated with the Oak Ridge National Laboratory (ORNL) in Tennessee in one of his three affiliations. His other institutions listed on the papers include universities in Singapore and China.

However, an official from the Nanyang Technological University (NTU) in Singapore, told us the work in the now-retracted papers was not carried out at the NTU either.

Here’s the first of the retraction notices, issued on August 8: Continue reading Where was chem research conducted? Not here, say two of three listed author affiliations

UK tribunal orders release of data from controversial chronic fatigue syndrome study

court caseA tribunal in the UK has rejected an appeal by Queen Mary University of London, who sought to reverse a previous order that they release data from a controversial 2011 paper in The Lancet about chronic fatigue syndrome (CFS).

The decision is one in a long series of judgments about the so-called PACE trial, which reported that two treatments — known as cognitive behavioral therapy and graded exercise therapy — helped alleviate the symptoms of the condition. But ever since The Lancet article and follow-up papers have been published, patients and critics have questioned the conclusions and clamored to see the raw data.

The main criticisms: The findings may prompt some to believe chronic fatigue is a mental, not a physical, disorder, and the PACE program could actually be harmful to patients by encouraging too much exercise. These criticisms were recently bolstered by a re-analysis of the evidence by the Agency for Healthcare Research and Quality, which downgraded its original conclusions about the effectiveness of cognitive behavioral therapy and graded exercise therapy.

In March 2014,  Continue reading UK tribunal orders release of data from controversial chronic fatigue syndrome study